| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911964A Duck interleukin 2 acceptor alpha strand lyoregion protein monoclone antibody and its preparation method |
| 02/14/2007 | CN1911963A SARS neutralization antibody and application |
| 02/14/2007 | CN1911962A Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 02/14/2007 | CN1911960A Chlamydia protein, gene sequence and uses thereof |
| 02/14/2007 | CN1300320C Alzhimer's disease secretase |
| 02/14/2007 | CN1300307C Recombined T4 bacteriophage of expressing cholecystokinin gene |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300172C Immunoglobulin antibody against SARS-CoV and its preparing method |
| 02/14/2007 | CN1300170C Novel DnaJ/Hsp40 molecule DC-DJIII, its coding sequence and application |
| 02/14/2007 | CN1300139C Haptens, immunogens, antibodies and conjugates for 2-oxo-3-hydroxy LSD |
| 02/14/2007 | CN1299771C Colorstrum-based composition |
| 02/13/2007 | US7176300 Avian lysozyme promoter |
| 02/13/2007 | US7176299 Compounds |
| 02/13/2007 | US7176294 Transcription factor, BP1 |
| 02/13/2007 | US7176291 Using immunoglobulin transferase binding activity to diagnose cancer |
| 02/13/2007 | US7176290 Tau protein epitopes for use in the treatment of alzheimer's disease |
| 02/13/2007 | US7176289 Monoclonal antibody or fragment which binds to an eight amino acid epitope of the sequence glutamine-serine-arginine-aspartic acid-threonine-glutamic acid-valine-leucine present within amino acids 175 536 of SEQ ID NO: 4 in a diluent or excipient; modulator screening; antitumor and -carcinogenic agents |
| 02/13/2007 | US7176285 Ligands for human protein histidine phosphatase (PHP1); identifying agonists and antagonists and treating conditions associated with PHPIP-120 imbalance with the identified compounds; cardiovascular disorders; autism; schizophrenia; antiarthritic and -carcinogenic agents; Bardet-Beidl Syndrome; anemia |
| 02/13/2007 | US7176277 Conversion of apoptotic proteins |
| 02/13/2007 | US7176275 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107, antibodies specific for the peptides and methods of stimulating immune response; antisense agents |
| 02/13/2007 | US7176190 Comprises transgenic potato which generates starch with modified viscosity and phosphate characteristics; for enhancing quality of paper, cardboard, adhesive, textile, plaster, concrete, fertilizer, medicine and toothpaste; improving animal feeds |
| 02/13/2007 | US7176184 Treatment for inflammatory bowel disease with a fibronectin polypeptide |
| 02/13/2007 | US7176181 Enhancement or inhibition of the interactions of galectin-8 and galectin-8-like proteins with other extracellular matrix proteins or cell surface receptors; the use of modulators of cell adhesion; antitumor, -carcinogenic, -metastasis agents |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7175996 Methods of optimizing antibody variable region binding affinity |
| 02/13/2007 | US7175993 Taxol immunoassay |
| 02/13/2007 | US7175990 Prognosticating probability of pregnancy via selectin concentration; in vitro fertilization |
| 02/13/2007 | US7175989 Antibodies to trisulfated heparin disaccharide in painful sensory axonal neuropathy |
| 02/13/2007 | US7175988 Human G-protein Chemokine Receptor (CCR5) HDGNR10 |
| 02/13/2007 | US7175849 Polypeptide for use in the treatment of viral disorders |
| 02/13/2007 | US7175847 for the treatment of autoimmune disorders, and the prevention of organ rejection |
| 02/13/2007 | US7175846 Cancerous disease modifying antibodies |
| 02/13/2007 | US7175845 providing passive immunity against ricin intoxication in a subject |
| 02/13/2007 | US7175843 Methods for selectively stimulating proliferation of T cells |
| 02/13/2007 | CA2510981C Fibrin sealant compositions and methods for utilizing same |
| 02/13/2007 | CA2219947C Monoclonal antibody reactive to human cetp and assay method for human cetp |
| 02/13/2007 | CA2177959C Homologous recombination antibody expression system for murine cells |
| 02/13/2007 | CA2124958C Inhibitory immunoglobulin polypeptides to human pdgf beta receptor |
| 02/13/2007 | CA2084987C Nucleic acid ligands |
| 02/12/2007 | CA2553115A1 Modulation of peroxisome proliferation-activated receptors |
| 02/08/2007 | WO2007016597A2 Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy |
| 02/08/2007 | WO2007016285A2 M-csf specific monoclonal antibody and uses thereof |
| 02/08/2007 | WO2007016240A2 Use of antibody to m-csf |
| 02/08/2007 | WO2007016185A2 Mono-and bi-functional antibody conjugates as effective adjuvants of protein vaccination |
| 02/08/2007 | WO2007015848A2 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 02/08/2007 | WO2007015771A2 Composition and method for introduction of rna interference sequences into targeted cells and tissues |
| 02/08/2007 | WO2007014991A1 Antibodies directed against a ldl receptor |
| 02/08/2007 | WO2007014743A2 Cd33-specific single-chain immunotoxin and method of use |
| 02/08/2007 | WO2007014463A1 Nalp7-based diagnosis of female reproductive conditions |
| 02/08/2007 | WO2007014460A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014459A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014458A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014457A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014456A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014455A1 Cancerous disease modifying antibodies |
| 02/08/2007 | WO2007014415A1 Helminth antigen and immunotherapy |
| 02/08/2007 | WO2006130458A3 Antibodies directed to cd20 and uses thereof |
| 02/08/2007 | WO2006121852A3 Anti-cd19 antibody therapy for autoimmune disease |
| 02/08/2007 | WO2006077442A3 Inhibition of islet amyloid polypeptide (iapp) aggregation for the treatment of type 2 diabetes |
| 02/08/2007 | WO2006076584A3 Kid31 and antibodies that bind thereto |
| 02/08/2007 | WO2006067506A3 Hiv resistance genes |
| 02/08/2007 | WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 02/08/2007 | WO2006050834A3 Antibodies against tenascin-c |
| 02/08/2007 | WO2006048174A3 Immunoglobulin fractions |
| 02/08/2007 | WO2005110490A8 Phospholipase c gamma modulation and uses thereof for management of pain and nociception |
| 02/08/2007 | US20070033669 Semaphorin gene family |
| 02/08/2007 | US20070033661 Suppression of B-cell apoptosis in transgenic animals expressing humanized immunoglobulin |
| 02/08/2007 | US20070032643 Cis-element regulating transcription, transcriptional regulatory factor binding specifically thereto and use of the same |
| 02/08/2007 | US20070032642 Novel genes and their use in the modulation of obesity, diabetes and energy imbalance |
| 02/08/2007 | US20070032639 Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation |
| 02/08/2007 | US20070032637 a crystal complex of an epidermal growth factor (EGF) and an epidermal growth factor receptor (EGFR), used for screening and for designing the substance that regulate EGFR activity |
| 02/08/2007 | US20070032636 Chimeric retroviral Gag genes and screening assays |
| 02/08/2007 | US20070032635 Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
| 02/08/2007 | US20070032433 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070032416 Chorionic somatomammotropin hormone splice variants |
| 02/08/2007 | US20070032415 Compositions, splice variants and methods relating to breast specific genes and proteins |
| 02/08/2007 | US20070032413 Of given amino acid sequence; vectors, host cells, and recombination; diagnosing and treating diseases related to human secreted proteins |
| 02/08/2007 | US20070031979 Protein biopolymer markers predictive of type II diabetes |
| 02/08/2007 | US20070031955 Compositions and methods for refolding of denatured proteins |
| 02/08/2007 | US20070031931 Biosynthetic binding proteins for immuno-targeting |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031922 Nucleotide sequences coding chimeric immunoglobulin comprising salavage receptor binding epitope for use as reporter in immunodiagnostic and immunotherapeutics |
| 02/08/2007 | US20070031904 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031903 Mammalian IAP gene family, primers, probes and detection methods |
| 02/08/2007 | US20070031901 Using maytansinoid conjugated monoclonal antibody to treat cell proliferative disorders |
| 02/08/2007 | US20070031896 Anti-CCR4 antibodies and methods of use therefor |
| 02/08/2007 | US20070031894 Novel nerve stem cell marker |
| 02/08/2007 | US20070031888 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/08/2007 | US20070031878 Methods and compositions for polypeptide engineering |
| 02/08/2007 | US20070031860 G-protein coupled receptor and uses therefor |
| 02/08/2007 | US20070031855 Receptor for a bacillus thuringiensis toxin |
| 02/08/2007 | US20070031854 Novel 10,10'-substituted-9,9'-biacridilidine luminescent molecules their preparation and uses |
| 02/08/2007 | US20070031842 379 human secreted proteins |
| 02/08/2007 | US20070031835 Diagnosis of advanced cancer |
| 02/08/2007 | US20070031484 Immunoliposomes that optimize internationalization into target cells |
| 02/08/2007 | US20070031452 rheumatoid arthritis; nervous system disorders; endogenous retroviral elements (ERV) |
| 02/08/2007 | US20070031449 A Neisserial bacterium in which the expression of an Imp protein is functionally downregulated so that the level of lipopolysaccharide in the outer membrane is decreased compared to the wild-type; outer membrane vesicle preparations used as vaccines |
| 02/08/2007 | US20070031445 Compositions and methods for enhancing immune responses mediated by antigen-presenting cells |